Richard Liu

Richard Liu, CFA, currently serves as Chief Financial Officer at HeMemics Biotechnologies, Inc., a position held since 2021. Prior to this, Richard Liu was the Managing Member at U-Star, LLC from 2016 to 2021 and worked as an Auditor for the US Government Accountability Office in 2018-2019. Richard Liu's career also includes roles as a Trader/Analyst at Abingdon Capital Management from 2004 to 2016, Investment Analyst at Bethsteel Pension Management from 2001 to 2003, and Equity Research Summer Associate at JOHN HANCOCK FUNDS, INC. in 2000. Early in Richard Liu's career, experience as a Senior Auditor in the Investment Company Practice at MCGLADREY & PULLEN, LLP was gained from 1997 to 1999. Richard Liu holds a Bachelor of Business Administration in Accounting from Baruch College and an MBA in Finance from Cornell Johnson Graduate School of Management.